Piper Sandler Starts Pelthos Therapeutics (PTHS) at Overweight Feb 27, 2026 01:10AM
Pelthos Therapeutics (PTHS) files $200M mixed shelf Feb 2, 2026 04:48PM
Horizon Technology provides $50 million loan facility to Pelthos Jan 15, 2026 04:10PM
Pelthos Therapeutics secures $50 million credit facility from Horizon Jan 13, 2026 08:31AM
Pelthos Therapeutics acquires Xeglyze head lice treatment for $1.8 million Jan 5, 2026 07:30AM


Jan 2, 2026 04:50PM Pelthos acquires head lice treatment assets for $1.8 million
Dec 23, 2025 06:00PM Pelthos Therapeutics appoints Andrew Einhorn to board of directors
Dec 4, 2025 07:02AM Pelthos signs pharmacy benefit manager deal for molluscum treatment
Dec 3, 2025 06:07AM H.C. Wainwright Starts Pelthos Therapeutics (PTHS) at Buy
Nov 25, 2025 03:19AM Roth/MKM Starts Pelthos Therapeutics (PTHS) at Buy
Nov 14, 2025 07:06AM Pelthos Therapeutics (PTHS) PT Raised to $57 at Oppenheimer
Nov 13, 2025 06:47AM Pelthos Therapeutics Inc. (PTHS) reported Q3 result
Nov 7, 2025 08:01AM Pelthos Therapeutics acquires Xepi cream and raises $18 million
Oct 9, 2025 08:01AM Pelthos launches patient advocacy campaign for molluscum skin infection
Sep 2, 2025 06:04AM Oppenheimer Starts Pelthos Therapeutics (PTHS) at Outperform
Aug 18, 2025 04:47PM Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss of $5.38
Jul 2, 2025 07:01AM Ligand Pharma (LGND) Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics